Literature DB >> 18787961

Overexpression of CyclinD1 and underexpression of p16 correlate with lymph node metastases in laryngeal squamous cell carcinoma in Chinese patients.

Zhi-jie Fu1, Zhi-yong Ma, Qi-rong Wang, Da-peng Lei, Rong Wang, Chun-xi Liu, Xin-liang Pan.   

Abstract

BACKGROUND: CyclinD1 and p16 are involved in the regulation of G1 checkpoint and may play an important role in the tumorgenesis of laryngeal squamous cell carcinoma (LSCC). Previous studies have examined the level of expression of cyclinD1 or p16 in LSCC but no such information is available for their relation and their correlation with lymph node metastasis in Chinese patients. PATIENTS AND METHODS: A total of 58 patients underwent surgical resection of laryngeal tumours in the Department of Otolaryngology, Qilu Hospital Shandong University between January 2001 and December 2002. All pathologic specimens were available for immunohistochemical study using antibodies against cyclinD1 and p16.
RESULTS: Compared with normal epithelium, expression of CyclinD1 in the LSCC was significantly higher (62.1% vs. 10.0%, P < 0.05), expression of p16 was significantly lower (48.3% vs. 90.0%, P < 0.05); CyclinD1 expression in LSCC was up-regulated in TNM classification (r (s) = 0.409, P < 0.05) as well as with cervical lymph node metastases (r (s) = 0.294, P < 0.05); p16 expression in LSCC was down-regulated with cervical lymph node metastases (r (s) = -0.275, P < 0.05); negative significant correlation between p16 immunostaining and CyclinD1 was observed in LSCC (r (s) = -0.331, P < 0.05).
CONCLUSION: There was a negative correlation between CyclinD1 expression and p16 expression in LSCC. The over-expression of CyclinD1 and the under-expression of p16 may play a significant role in the incidence and development of LSCC and may be important indicators for cervical lymph node metastases in Chinese patients of LSCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18787961     DOI: 10.1007/s10585-008-9207-x

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  24 in total

1.  Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas.

Authors:  Y Dong; L Sui; K Sugimoto; Y Tai; M Tokuda
Journal:  Int J Cancer       Date:  2001-07-20       Impact factor: 7.396

2.  Differential expression of key cell cycle genes (p16/cyclin D1/pRb) in head and neck squamous carcinomas.

Authors:  S Lai; A K El-Naggar
Journal:  Lab Invest       Date:  1999-03       Impact factor: 5.662

Review 3.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

4.  Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications.

Authors:  A K El-Naggar; S Lai; G L Clayman; J H Zhou; S A Tucker; J Myers; M A Luna; W F Benedict
Journal:  Hum Pathol       Date:  1999-09       Impact factor: 3.466

5.  Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue.

Authors:  Tomasz Krecicki; Robert Smigiel; Marcin Fraczek; Marlena Kowalczyk; Maria M Sasiadek
Journal:  J Laryngol Otol       Date:  2004-09       Impact factor: 1.469

6.  Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors.

Authors:  Ali Namazie; Sassan Alavi; Olufunmilayo I Olopade; Giovanni Pauletti; Neema Aghamohammadi; M Aghamohammadi; Jeffrey A Gornbein; Thomas C Calcaterra; Dennis J Slamon; Marilene B Wang; Eri S Srivatsan
Journal:  Laryngoscope       Date:  2002-03       Impact factor: 3.325

7.  Growth suppression by p16ink4 requires functional retinoblastoma protein.

Authors:  R H Medema; R E Herrera; F Lam; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-03       Impact factor: 11.205

8.  Altered p16/MTS1/CDKN2 and cyclin D1/PRAD-1 gene expression is associated with the prognosis of squamous cell carcinoma of the esophagus.

Authors:  H Takeuchi; S Ozawa; N Ando; C H Shih; K Koyanagi; M Ueda; M Kitajima
Journal:  Clin Cancer Res       Date:  1997-12       Impact factor: 12.531

9.  Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis.

Authors:  J Bartkova; J Lukas; M Strauss; J Bartek
Journal:  Oncogene       Date:  1995-02-16       Impact factor: 9.867

10.  Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma.

Authors:  Ho-Sheng Lin; Gerald J Berry; Zijie Sun; Willard E Fee
Journal:  World J Surg Oncol       Date:  2006-09-05       Impact factor: 2.754

View more
  10 in total

1.  Expression of phosphorylated Stat5 predicts expression of cyclin D1 and correlates with poor prognosis of colonic adenocarcinoma.

Authors:  Yinling Mao; Zhiwei Li; Changjie Lou; Yanqiao Zhang
Journal:  Int J Colorectal Dis       Date:  2010-11-16       Impact factor: 2.571

2.  The role of protein p16(INK4a) in glottic laryngeal squamous cell carcinoma.

Authors:  David Kalfert; Petr Celakovsky; Jan Laco; Marie Ludvikova
Journal:  Pathol Oncol Res       Date:  2014-04-24       Impact factor: 3.201

3.  Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma.

Authors:  Mustafa Fuat Acikalin; Durmus Etiz; Melek Kezban Gurbuz; Erkan Ozudogru; Funda Canaz; Ertugrul Colak
Journal:  Med Oncol       Date:  2011-05-07       Impact factor: 3.064

Review 4.  The prognostic value of cyclin D1 expression in head and neck squamous cell carcinoma.

Authors:  Federico M Gioacchini; Matteo Alicandri-Ciufelli; Shaniko Kaleci; Giuseppe Magliulo; Livio Presutti; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-12-12       Impact factor: 2.503

5.  BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer.

Authors:  Xiao-Wei Zhang; Ya-Ping Sheng; Qian Li; Wei Qin; You-Wei Lu; Yu-Fan Cheng; Bing-Ya Liu; Feng-Chun Zhang; Jin Li; Goberdhan P Dimri; Wei-Jian Guo
Journal:  Mol Cancer       Date:  2010-02-21       Impact factor: 27.401

6.  A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma.

Authors:  Xin Zhao; Tao Song; Zhoukang He; Lian Tang; Yimin Zhu
Journal:  Med Oncol       Date:  2009-10-06       Impact factor: 3.064

7.  The role of protein p16INK4a in non-oropharyngeal head and neck squamous cell carcinoma in Southern China.

Authors:  Hang Yang; Ye Cao; Zhi-Ming Li; Ya-Jun Li; Wen-Qi Jiang; Yan-Xia Shi
Journal:  Oncol Lett       Date:  2018-08-23       Impact factor: 2.967

8.  Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma.

Authors:  Haoxun Wang; Jing Wang; Bingbo Zhao
Journal:  Oncol Lett       Date:  2019-03-26       Impact factor: 2.967

9.  RhoT1 and Smad4 are correlated with lymph node metastasis and overall survival in pancreatic cancer.

Authors:  Hua Jiang; Chengzhi He; Shasha Geng; Haihui Sheng; Xiaoying Shen; Xiaoyan Zhang; Hang Li; Shizhang Zhu; Ximei Chen; Changqing Yang; HengJun Gao
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

10.  PinX1 suppresses bladder urothelial carcinoma cell proliferation via the inhibition of telomerase activity and p16/cyclin D1 pathway.

Authors:  Jian-Ye Liu; Dong Qian; Li-Ru He; Yong-Hong Li; Yi-Ji Liao; Shi-Juan Mai; Xiao-Peng Tian; Yan-Hui Liu; Jia-Xing Zhang; Hsiang-Fu Kung; Yi-Xin Zeng; Fang-Jian Zhou; Dan Xie
Journal:  Mol Cancer       Date:  2013-11-23       Impact factor: 27.401

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.